Literature DB >> 6286922

Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.

W E Heydorn, D J Brunswick, A Frazer.   

Abstract

The effect of administration of antidepressant drugs to rats on catecholamine-induced rises in the concentration of melatonin in the pineal gland and serum was studied. Increases in melatonin levels were produced by either the exogenous administration of different doses of L-isoproterenol or by exposure of rats to darkness. Repeated administration of either desmethylimipramine or nialamide reduced significantly the elevation in melatonin concentrations in the pineal gland produced by either L-isoproterenol or darkness. The rise in serum melatonin seen at night was also blunted significantly in rats treated repeatedly with these drugs. By contrast, the concentration of melatonin in either the pineal gland or serum was not reduced in rats given desmethylimipramine or nialamide acutely. In fact, daytime concentrations of melatonin both in the gland and in serum were significantly increased after either acute or repeated treatment with nialamide. The nialamide-induced increase in daytime concentrations of melatonin in the pineal gland was prevented if the rats were treated with propranolol. The diminished hormonal responsiveness produced by the repeated administration of antidepressants occurred at a time when the binding of [3H]dihydroalprenolol to pineal gland homogenates was reduced. Thus, a hormonal response to catecholamines regulated via beta adrenergic receptor activation is reduced by repeated antidepressant treatments in conjunction with the development of beta adrenergic receptor subsensitivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286922

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.

Authors:  K Demisch; L Demisch; T Nickelsen; R Rieth
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys.

Authors:  D L Murphy; N A Garrick; J L Hill; L Tamarkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Performance and extinction of lever press behavior following chronic administration of desipramine to rats.

Authors:  I Lucki; A Frazer
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission.

Authors:  P J Cowen; A R Green; D G Grahame-Smith; L E Braddock
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

5.  The hypothalamic and neurohypophysial oxytocin content as influenced by desmethylimipramine in normal and pinealectomized white male rats.

Authors:  J W Guzek; M Juszczak
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.

Authors:  S A Checkley; C Thompson; S Burton; C Franey; J Arendt
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.

Authors:  Gillian W Reierson; Claudio A Mastronardi; Julio Licinio; Ma-Li Wong
Journal:  Clin Pharmacol       Date:  2009-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.